Elokom lotion 0.1%, 30ml

Inflammatory reactions and itching in dermatoses amenable to GCS therapy.

Outwardly.
Apply a few drops of ElokomЃ Lotion to the affected skin once a day. After application, rub in with gentle massaging movements until completely absorbed from the skin surface. For the most effective and economical use of the drug, bring the nozzle of the bottle to the affected area of ??the skin and gently squeeze the bottle.
The duration of the course of treatment is determined by the doctor based on the assessment of the effectiveness of the drug, as well as the patient's tolerance of the drug, the presence and severity of side effects.

Active substance:

mometasone furoate - 1 mg

Excipients:

isopropanol - 400 mg, propylene glycol - 300 mg, hyprolose - 1.5 mg, sodium dihydrogen phosphate dihydrate - 2.26 mg, phosphoric acid 85% - qs until pH 3.5-5.5, purified water - qs up to 1000 mg.

Hypersensitivity to mometasone; rosacea; perioral dermatitis; bacterial, viral (Herpes simplex, Herpes zoster, chickenpox), fungal skin infection; tuberculosis; syphilis; post-vaccination reactions; pregnancy (use on large areas of the skin, long-term treatment); lactation period (use in high doses and / or for a long time); children under 2 years of age.

Use with caution on the face and intertriginous skin, use occlusive dressings, and apply on large areas of the skin and / or for a long time (especially in children).

Composition:

Active substance:

mometasone furoate - 1 mg

Excipients:

isopropanol - 400 mg, propylene glycol - 300 mg, hyprolose - 1.5 mg, sodium dihydrogen phosphate dihydrate - 2.26 mg, phosphoric acid 85% - qs until pH 3.5-5.5, purified water - qs up to 1000 mg.

Clinical and pharmacological group: GCS for external use

Pharmaco-therapeutic group: Topical glucocorticosteroid

pharmachologic effect

GCS for external use. It has anti-inflammatory, antipruritic and antiexudative effects. GCS induce the release of proteins that inhibit phospholipase A2, known collectively as lipocortins, which control the biosynthesis of inflammatory mediators such as prostaglandins and leukotrienes by inhibiting the release of their common precursor, arachidonic acid.

Pharmacokinetics

Absorption of the drug when applied externally is negligible. 8 hours after application to intact skin (without an occlusive dressing), 0.7% of mometasone is found in the systemic circulation.

Indications of active substances of the drug ElokomЃ Lotion

Inflammatory reactions and itching in dermatoses amenable to GCS therapy.

Method of administration and dosage

Outwardly.
Apply a few drops of ElokomЃ Lotion to the affected skin once a day. After application, rub in with gentle massaging movements until completely absorbed from the skin surface. For the most effective and economical use of the drug, bring the nozzle of the bottle to the affected area of ??the skin and gently squeeze the bottle.
The duration of the course of treatment is determined by the doctor based on the assessment of the effectiveness of the drug, as well as the patient's tolerance of the drug, the presence and severity of side effects.

Side effect

Infections and invasions: rarely - folliculitis, secondary infection.

On the part of the skin and subcutaneous tissues: rarely - irritation and dryness of the skin, burning sensation, itching, hypertrichosis, acne, hypopigmentation, perioral dermatitis, allergic contact dermatitis, accession of a secondary infection, skin maceration, signs of skin atrophy, striae, prickly heat, formation papules, pustules.

From the nervous system: the frequency has not been established - paresthesia.

When using external forms of GCS for a long time and / or for the treatment of large areas of skin, or using occlusive dressings, especially in children and adolescents, side effects characteristic of systemic GCS, including adrenal insufficiency and Cushing's syndrome, may occur.

Contraindications for use

Hypersensitivity to mometasone; rosacea; perioral dermatitis; bacterial, viral (Herpes simplex, Herpes zoster, chickenpox), fungal skin infection; tuberculosis; syphilis; post-vaccination reactions; pregnancy (use on large areas of the skin, long-term treatment); lactation period (use in high doses and / or for a long time); children under 2 years of age.

Use with caution on the face and intertriginous skin, use occlusive dressings, and apply on large areas of the skin and / or for a long time (especially in children).

Application during pregnancy and lactation

It is contraindicated to use during pregnancy on large areas of the skin, for a long time; during breastfeeding.

Application in children

Contraindication: children under 2 years of age.

special instructions

When applied on large areas of the skin for a long time, especially when using occlusive dressings, the development of a systemic action of GCS is possible. Given this, patients should be monitored for signs of suppression of the function of the hypothalamic-pituitary-adrenal system and the development of Cushing's syndrome.

It should be borne in mind that GCS can change the manifestations of some skin diseases, which can complicate the diagnosis. In addition, the use of GCS can cause delayed wound healing.

With prolonged therapy with GCS, a sudden cessation of therapy can lead to the development of rebound syndrome, manifested in the form of dermatitis with intense redness of the skin and a burning sensation. Therefore, after a long course of treatment, the drug should be withdrawn gradually, for example, by switching to an intermittent treatment regimen before completely stopping it.

Any of the side effects described with the systemic use of GCS, including suppression of adrenal function, can also occur with external use, especially in children.

Use in pediatrics

Due to the fact that in children the value of the ratio of surface area and body weight is greater than in adults, children are at a greater risk of suppression of the function of the hypothalamic-pituitary-adrenal system and the development of Cushing's syndrome with the use of any localized corticosteroids. Prolonged use of corticosteroids in children can lead to impaired growth and development.

In children, it should be used in the lowest effective dose.

Impact on the ability to drive a car or moving machinery

The effect of the drug ElokomЃ Lotion on the ability to drive a car or moving machinery was not observed.

Release form

Solution for external use 0.1%. 30 ml in a dropper bottle made of low density polyethylene. The dropper bottle is closed with a screw-on plastic cap. 1 dropper bottle together with instructions for use is placed in a cardboard box.

Storage conditions

Store at temperatures between 2 and 25 ? C.
Keep out of the reach of children.

Shelf life

3 years.
Do not use after the expiration date.

Conditions of dispensing from pharmacies

On prescription.